*Yersinia spp.*******

Yersinia genus: Yersinia pestis, Yersinia enterocolitica, and Yersinia pseudotuberculosis. These bacteria can cause diseases ranging from gastrointestinal infections to severe systemic illnesses like the plague.

Overview of Yersinia spp.

  1. Diseases Caused by Pathogenic Yersinia Species:

    • Y. pestis is infamous for causing the plague, which devastated Europe during the Black Death, killing an estimated 30% of the population (~100 million people). While still a health concern, with around 1,000–5,000 cases reported to the WHO annually, modern antibiotic treatments have significantly reduced mortality rates.

    • Y. enterocolitica and Y. pseudotuberculosis are less severe pathogens, primarily causing gastrointestinal illness, with symptoms such as diarrhea and lymph node infections.

  2. Yersinia spp. Virulence Factors:

    • Common Virulence Factors:

      • All three species possess a Type III Secretion System (T3SS), which functions like a molecular syringe to inject effector proteins (Yops) into host cells.

      • The Yop effector proteins include YopE, YopH, YopO, YopP, and YopT. These proteins inhibit host cell processes like phagocytosis by manipulating the actin cytoskeleton within immune cells.

    • Specific Virulence Factors:

      • Y. pestis has additional genes for biofilm formation, which are essential for survival in the flea host. The biofilms clog the flea’s digestive tract, leading to increased feeding attempts and facilitating the transmission of the bacteria into the bloodstream of mammals.

      • Invasin, an outer membrane protein, is present in Y. enterocolitica and Y. pseudotuberculosis but absent in Y. pestis. Invasin binds to β1 integrin receptors on M cells in the intestine, promoting bacterial uptake.

Plague and Transmission of Yersinia pestis

  • Types of Plague:

    • Bubonic Plague:

      • Characterized by the swelling of lymph nodes (buboes).

      • The bacteria can spread to the bloodstream (septicemia), leading to tissue death and internal hemorrhaging.

    • Pneumonic Plague:

      • Involves infection of the lungs.

      • Can be spread via aerosolized bacteria and cause death due to pneumonia or septic shock.

  • Use as a Bioweapon:

    • Y. pestis is a potential bioweapon due to its high mortality if left untreated. However, its survival outside of hosts is limited, and no effective aerosolized form has been developed. Resistance to antibiotics could increase its threat level.

Enteropathogenic Yersinia spp.

  1. Infection Mechanisms:

    • Y. enterocolitica and Y. pseudotuberculosis infect the intestines, causing diarrhea, and may disseminate to lymph nodes and blood, leading to complications like septic shock.

    • They exploit the natural function of M cells in the gut, which deliver antigens to immune cells, to initiate infection.

  2. Epidemiology:

    • Y. enterocolitica is a food-borne pathogen, often linked to pigs, and is the third most reported bacterial enteric illness in New Zealand.

Evolution and Genetic Relationships

  • The three species share a high degree of genetic similarity (97% identical genomes). Y. pestis and Y. pseudotuberculosis diverged relatively recently (1,500–20,000 years ago), whereas Y. enterocolitica separated from this lineage about 100–200 million years ago.

  • All three species harbor a plasmid (pYV) that encodes the T3SS and Yop effectors.

Mechanism of Virulence Factors

  1. Type III Secretion System (T3SS):

    • Allows the bacteria to deliver Yop effectors directly into host cells, disrupting immune cell function.

    • YopE and YopT inhibit Rac and Cdc42, small GTPases involved in actin polymerization, thereby blocking the host's ability to phagocytose the bacteria.

  2. Biofilm Formation in Y. pestis:

    • Occurs in the flea's digestive tract, promoting transmission to humans during feeding.

  3. Invasin in Y. enterocolitica and Y. pseudotuberculosis:

    • Binds to β1 integrins on M cells in the intestinal mucosa, facilitating bacterial uptake.

    • Invasin mimics the human protein fibronectin, utilizing similar amino acid residues for integrin binding.

Identification of Invasin and Its Human Receptor

  1. Discovery of Invasin:

    • Invasin was identified by screening for genes that allowed a non-pathogenic bacterium (E. coli) to infect human cells.

    • The invasin gene was cloned from Y. pseudotuberculosis, conferring the ability to bind human cells when expressed in E. coli.

  2. Discovery of β1 Integrin Receptors:

    • The human receptor for invasin was identified through affinity chromatography, followed by mass spectrometry to match peptide fingerprints with known proteins.

    • This led to the discovery of β1 integrins as the receptors.

Molecular Mimicry

  • Invasin and the human protein fibronectin share similar binding mechanisms for β1 integrins, illustrating molecular mimicry. This allows the bacterial protein to effectively engage the host's cellular machinery.

Yersinia species demonstrate diverse mechanisms of pathogenesis, ranging from gastrointestinal infections to the deadly plague. The T3SS and Yop effectors play critical roles across the species, while specific adaptations, such as biofilm formation and invasin-mediated internalization, contribute to the pathogenic versatility of these bacteria. Understanding these mechanisms can provide insights into developing targeted treatments and preventive strategies.